Innovative MedTech Inc (OTCMKTS:IMTH) Stock In Focus After Recent Development

Provider of health and wellness services, Innovative MedTech Inc (OTCMKTS:IMTH) on April 18, 2022, announced that the RX Vitality digital healthcare wallet will offer 20%-75% pharmaceutical discounts at 65,000 pharmacies across the United States.

Market Reaction

On Monday, IMTH stock gained 5% to $1.05 with more than 3k shares, compared to its average volume of 467 shares. The stock moved within a range of $1.0400 – 1.9000 after opening trade at $1.50.

Innovative MedTech Adds OTC Pharma Discounts to Its Loyalty Program

Innovative MedTech plans to provide wellness and health discounts at 500+ online merchants and earning points on the Loyalty Program. The surging costs of OTC drugs is a huge concern for substantial number of Americans especially as medications can become unaffordable.

Michael Friedman, President & CEO said that the firm’s mission to broaden access to affordable care. Friedman added that TruCash has provided the firm with many benefits to its customers. The CEO further opined that addition of OTC pharmaceutical discounts will be amongst the list of other benefits. Innovative MedTech believes that the company will be harnessing the need of giving an effective tool for reducing long term healthcare costs for substantial number of Americans.

Once this is implemented, the firm’s digital healthcare can be accessed by customers through mobile wallet both on Android and Apple stores. It is also aiming to have physical healthcare card.

Innovative MedTech Inc has two divisions: RX Vitality digital wallet and health care app under development. The company’s owned subsidiary SarahCare is an adult day care center franchisor with presence across twenty-six locations in the entire country.

Key Quote

“Our mission is to widely broaden the access to affordable care. TruCash has really provided us with some great potential benefits for our customers. By adding OTC pharmaceutical discounts to our list of other benefits, we believe that we will be tapping into a need for Americans and providing an effective tool for reducing their long term healthcare costs”, said Michael Friedman, President & CEO of the Company.


Leave a Reply

Your email address will not be published.